NITI Aayog member (Health) Dr VK Paul on Friday confirmed hat India is in talks with Johnson and Johnson for their single dose Covid-19 vaccine named Janssen.
Speaking to ANI, Dr Paul said, “We are in talks with Johnson and Johnson regarding their single-dose vaccine.”
He said that “as per the plan, this vaccine will also be produced in Hyderabad’s Bio E.”
The US pharma giant said late on Thursday that its Covid-19 vaccine showed strong promise against the Delta variant and other emerging strains and also promise against the Delta variant and other emerging strains and also provided durable protection against the infection more broadly. The healthcare company in a statement said that its vaccine was 85 per cent effective and could also help prevent hospitalization and death.
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…
https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…
Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…
Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…
https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…
A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…